Application list for self inspection and registration of 7 clinical trial data

The official website of the State Drug Administration announced that it had decided to verify the clinical trial data of seven newly received drug registration applications that had completed the clinical trial declaration and production. According to the announcement, before the inspection organized by the State Drug Administration, if the drug registration applicant finds the authenticity of the drug clinical trial data through self inspection, he / she shall withdraw the registration application actively, and the State Drug Administration shall publish the list of drug registration applicants, and shall not investigate their responsibilities.The food and drug audit and inspection center of the State Drug Administration will publicize the on-site inspection plan on its website, and notify the drug registration applicant and its local provincial drug regulatory department. After 10 working days of publicity, the center will notify the on-site inspection date and no longer accept the withdrawal application of the drug registration applicant. For the applicant, the person in charge and manager of drug clinical trial, and the person in charge of contract research organization who found data fraud in the on-site verification of drug clinical trial data, SDA will deal with it seriously according to law. Application list for self inspection and registration of clinical trial data of 7 drugs
2026-08-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
-
Rare diseases pose a challenge to thepharmaceutical industry
Recommend Reading
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Europe’s Chemicals Industry Stalls Again as Cefic Cuts 2025 Outlook
-
The Great Hydrogen Reality Check: Global Clean Hydrogen Projects Face Mass Cancellations
-
LG Chem and GS Caltex in Talks to Merge Yeosu Cracker Assets as Korea Pushes Industry Restructuring
-
ConocoPhillips to Cut Up to 25% of Workforce as Oil Price Slump Bites
-
Weekly Caustic Soda Price Consolidation Trend (6.22-6.26) in China
-
This week, the styrene market in China showed a weak decline (6.22-6.26)
-
Butadiene rubber prices fall back to pre-Middle East conflict levels in China
-
This Week's Maleic Anhydride Market Continues to Decline in China
-
Global Butadiene Market Faces Heavy Headwinds as Supply Surge Outpaces Demand